Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): A double-blind, randomised, factorial design, placebo-controlled trial

European Journal of Nutrition

Volumn 49, Issue 8, 2010, Pages 483-492

  O'Doherty, Mark G ^a,d   Gilchrist, Sarah E C M ^a   Young, Ian S ^a   McKinley, Michelle C ^a   Yarnell, John W G ^a   Gey, K Fred ^b   Evans, Alun ^a   Skidmore, Paula M L ^c   Woodside, Jayne V ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Antioxidant vitamins; Asymmetric dimethylarginine; B vitamins; C reactive protein; Cardiovascular disease; Homocysteine

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE; PYRIDOXINE; VITAMIN B GROUP;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADULT; ANTIOXIDANTS; ARGININE; ASCORBIC ACID; BETA CAROTENE; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HOMOCYSTEINE; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; PROTECTIVE AGENTS; TRIGLYCERIDES; VITAMIN B COMPLEX; VITAMIN E;

EID: 78650679877     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-010-0107-x     Document Type: Article

References (66)

1. H Lenzen D Tsikas RH Boger 2006 Asymmetric dimethylarginine (ADMA) and the risk for coronary heart disease: the multicenter CARDIAC study Eur J Clin Pharmacol 62 Suppl 13 45 49 10.1016/j.ahj.2006.06.005 1:CAS:528: DC%2BD28XhslCjs7g%3D 10.1007/s00228-005-0014-x (Pubitemid 44251196)
2. Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ, Goudeva L, et al. (2006) Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter coronary artery risk determination investigating the influence of ADMA concentration (CARDIAC) study. Am Heart J 152(3):493.e1-8. doi: 10.1016/j.ahj.2006.06.005 (Pubitemid 44251196)
3. TM Lu YA Ding MJ Charng SJ Lin 2003 Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease Clin Cardiol 26 10 458 464 10.1002/clc.4960261006 10.1002/clc.4960261006
4. Szuba A, Podgorski M (2006) Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor-evidence from epidemiological and prospective clinical trials. Pharmacol Rep 58 Suppl:16-20
5. Landmesser U, Hornig B, Drexler H (2004) Endothelial function: a critical determinant in atherosclerosis? Circulation 109(21 Suppl 1):II27-33. doi: 10.1161/01.CIR.0000129501.88485.1f
6. P Vallance J Leiper 2004 Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway Arterioscler Thromb Vasc Biol 24 6 1023 1030 10.1161/01.ATV.0000128897.54893.26 1:CAS:528:DC%2BD2cXkt1Ogt74%3D 10.1161/01.ATV.0000128897.54893.26 (Pubitemid 38737826)
7. CT Tran JM Leiper P Vallance 2003 The DDAH/ADMA/NOS pathway Atheroscler Suppl 4 4 33 40 10.1016/S1567-5688(03)00032-1 1:CAS:528:DC%2BD3sXps1Gmtbk%3D 10.1016/S1567-5688(03)00032-1 (Pubitemid 38234493)
8. R Maas 2005 Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA) Vasc Med 10 Suppl 1 S49 S57 10.1177/1358836X0501000108 10.1177/1358836X0501000108
9. RH Boger K Sydow J Borlak T Thum H Lenzen B Schubert, et al. 2000 LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases Circ Res 87 2 99 105 1:CAS:528:DC%2BD3cXlt1aitbo%3D
10. JL Jiang NS Li Ns YJ Li HW Deng 2002 Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level Br J Pharmacol 135 5 1175 1182 10.1038/sj.bjp.0704563 1:CAS:528: DC%2BD38Xis1aitL8%3D 10.1038/sj.bjp.0704563
11. MC Stuhlinger RK Oka EE Graf I Schmolzer BM Upson O Kapoor, et al. 2003 Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine Circulation 108 8 933 938 10.1161/01.CIR.0000085067.55901.89 10.1161/01.CIR.0000085067.55901.89 (Pubitemid 37048221)
12. Boger RH, Lentz SR, Bode-Boger SM, Knapp HR, Haynes WG (2001) Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin Sci (Lond) 100(2):161-167
13. JV Woodside JW Yarnell D McMaster IS Young DL Harmon EE McCrum, et al. 1998 Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial Am J Clin Nutr 67 5 858 866 1:CAS:528:DyaK1cXislaju7g%3D
14. RR Packard P Libby 2008 Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction Clin Chem 54 1 24 38 10.1373/clinchem.2007.097360 1:CAS:528:DC%2BD1cXmtFelsg%3D%3D 10.1373/clinchem.2007.097360 (Pubitemid 351182593)
15. TA Pearson GA Mensah RW Alexander JL Anderson RO Cannon 3rd M Criqui, et al. 2003 Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association Circulation 107 3 499 511 10.1161/01.CIR.0000052939.59093.45 10.1161/01.CIR.0000052939.59093.45 (Pubitemid 36158056)
16. MP de Maat A Trion 2004 C-reactive protein as a risk factor versus risk marker Curr Opin Lipidol 15 6 651 657 10.1097/00041433-200412000-00005 (Pubitemid 39612983)
17. A May TJ Wang 2007 Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin Expert Rev Mol Diagn 7 6 793 804 10.1586/14737159.7.6.793 1:CAS:528:DC%2BD2sXhsVemurrF 10.1586/14737159.7.6.793 (Pubitemid 350171842)
18. A Leichtle D Teupser J Thiery 2006 Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects J Am Coll Nutr 25 5 420 428 1:CAS:528:DC%2BD28XhtFKqt7nK
19. JE Upritchard WH Sutherland JI Mann 2000 Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes Diabetes Care 23 6 733 738 0.2337/diacare.23.6.733 1:CAS:528:DC%2BD3cXnvV2is7Y%3D 10.2337/diacare.23.6.733
20. S Devaraj I Jialal 2000 Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients Free Radic Biol Med 29 8 790 792 10.1016/S0891-5849(00) 00420-2 1:CAS:528:DC%2BD3cXotFGqsL8%3D 10.1016/S0891-5849(00)00420-2
21. G Block CD Jensen TB Dalvi EP Norkus M Hudes PB Crawford, et al. 2009 Vitamin C treatment reduces elevated C-reactive protein Free Radic Biol Med 46 1 70 77 10.1016/j.freeradbiomed.2008.09.030 1:CAS:528:DC%2BD1cXhsFamsbbJ 10.1016/j.freeradbiomed.2008.09.030
22. G Block C Jensen M Dietrich EP Norkus M Hudes L Packer 2004 Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation J Am Coll Nutr 23 2 141 147 1:CAS:528: DC%2BD2cXjsleru7Y%3D
23. TS Church CP Earnest KA Wood JB Kampert 2003 Reduction of C-reactive protein levels through use of a multivitamin Am J Med 115 9 702 707 10.1016/j.amjmed.2003.08.024 1:CAS:528:DC%2BD3sXpvF2qsr0%3D 10.1016/j.amjmed. 2003.08.024 (Pubitemid 38032663)
24. KJ Woollard SJ Rayment R Bevan JA Shaw J Lunec HR Griffiths 2006 Alpha-tocopherol supplementation does not affect monocyte endothelial adhesion or C-reactive protein levels but reduces soluble vascular adhesion molecule-1 in the plasma of healthy subjects Redox Rep 11 5 214 222 10.1179/135100006X116727 1:CAS:528:DC%2BD28Xht1eit77E 10.1179/135100006X116727 (Pubitemid 44741628)
25. S Vega-Lopez N Kaul S Devaraj RY Cai B German I Jialal 2004 Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers Metabolism 53 2 236 240 10.1016/j.metabol.2003.09.012 1:CAS:528:DC%2BD2cXptFSqtw%3D%3D 10.1016/j.metabol.2003.09.012 (Pubitemid 38168897)
26. J Himmelfarb J Kane E McMonagle E Zaltas S Bobzin S Boddupalli, et al. 2003 Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease Kidney Int 64 3 978 991 10.1046/j.1523-1755.2003.00151. x 1:CAS:528:DC%2BD3sXntl2murg%3D 10.1046/j.1523-1755.2003.00151.x (Pubitemid 37013834)
27. N Kaul S Devaraj SM Grundy I Jialal 2001 Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects Am J Cardiol 87 11 1320 1323 10.1016/S0002-9149(01)01534-X 1:CAS:528:DC%2BD3MXjslemtLw%3D 10.1016/S0002-9149(01)01534-X (Pubitemid 32493884)
28. C Fumeron T Nguyen-Khoa C Saltiel M Kebede C Buisson TB Drueke, et al. 2005 Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients Nephrol Dial Transplant 20 9 1874 1879 10.1093/ndt/gfh928 1:CAS:528:DC%2BD2MXovVKqurs%3D 10.1093/ndt/gfh928 (Pubitemid 41222602)
29. Q Lu I Bjorkhem B Wretlind U Diczfalusy P Henriksson A Freyschuss 2005 Effect of ascorbic acid on microcirculation in patients with Type II diabetes: a randomized placebo-controlled cross-over study Clin Sci (Lond) 108 6 507 513 10.1042/CS20040291 1:CAS:528:DC%2BD2MXks1GltbY%3D 10.1042/CS20040291 (Pubitemid 40827558)
30. H Bruunsgaard HE Poulsen BK Pedersen K Nyyssonen J Kaikkonen JT Salonen 2003 Long-term combined supplementations with alpha-tocopherol and vitamin C have no detectable anti-inflammatory effects in healthy men J Nutr 133 4 1170 1173 1:CAS:528:DC%2BD3sXivVersrg%3D
31. BE van Aken J Jansen SJ van Deventer PH Reitsma 2000 Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells Blood Coagul Fibrinolysis 11 2 159 164
32. S Dalal SM Parkin S Homer-Vanniasinkam A Nicolaou 2003 Effect of homocysteine on cytokine production by human endothelial cells and monocytes Ann Clin Biochem 40 Pt 5 534 541 10.1258/000456303322326452 1:CAS:528: DC%2BD3sXot1Giu7c%3D 10.1258/000456303322326452 (Pubitemid 37152206)
33. JP Vuilleumier E Keck 1989 Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment J Micronut Analysis 5 25 34 1:CAS:528:DyaL1MXit1OqtLs%3D
34. JB Ubbink WJ Hayward Vermaak S Bissbort 1991 Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum J Chromatogr 565 1-2 441 446 10.1016/0378-4347(91)80407-4 1:CAS:528: DyaK3MXit1Crt7w%3D
35. GL Catignani JG Bieri WJ Driskell 1983 Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography Clin Chem 29 708 712 1:CAS:528:DyaL3sXhvFCns7g%3D
36. DI Thurnham E Smith PS Flora 1988 Concurrent liquid-chromatographic assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene, and β-cryptoxanthin in plasma, with tocopherol acetate as internal standard Clin Chem 34 377 378 1:CAS:528:DyaL1cXht1Orurc%3D
37. TM Reynolds A Brain 1992 A simple internally-standardised isocratic HPLC assay for vitamin B6 in human serum J Liquid Chromatogr 15 897 914 10.1080/10826079208018843 1:CAS:528:DyaK38XisFWgsb0%3D 10.1080/10826079208018843
38. T Teerlink RJ Nijveldt S de Jong PA van Leeuwen 2002 Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography Anal Biochem 303 2 131 137 10.1006/abio.2001.5575 1:CAS:528:DC%2BD38XislSgur8%3D 10.1006/abio.2001.5575 (Pubitemid 34407576)
39. KF Gey UK Moser P Jordan HB Stahelin M Eichholzer E Ludin 1993 Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C Am J Clin Nutr 57 5 Suppl 787S 797S 1:CAS:528:DyaK3sXksVyhtrw%3D
40. Department of Health (1991) Dietary reference values for food energy and nutrients for the United Kingdom. Report of the panel on dietary reference values of the committee on medical aspects of food policy. Report on heath and social subject's No. 41. HSMO, London
41. Gey KF (1998) Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors 7(1-2):113-174
42. R Saran JE Novak A Desai E Abdulhayoglu JS Warren R Bustami, et al. 2003 Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study Nephrol Dial Transplant 18 11 2415 2420 1:CAS:528:DC%2BD3sXot1Gjtrg%3D 10.1093/ndt/gfg406 (Pubitemid 37336835)
43. PW Nanayakkara JC Kiefte-de Jong PM ter Wee CD Stehouwer FJ van Ittersum MR Olthof, et al. 2009 Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD Am J Kidney Dis 53 1 41 50 10.1053/j.ajkd.2008.06.016 1:CAS:528:DC%2BD1MXhslyrtbc%3D 10.1053/j.ajkd.2008.06.016
44. B Schmitt M Wolters G Kressel O Hulsmann A Strohle WN Kuhn-Velten, et al. 2007 Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethylarginine (ADMA) in subjects with elevated risk for cardiovascular disease Atherosclerosis 193 1 168 176 10.1016/j.atherosclerosis.2006.06.007 1:CAS:528:DC%2BD2sXlvFamt7s%3D 10.1016/j.atherosclerosis.2006.06.007 (Pubitemid 46779119)
45. AM Spoelstra-de Man T Teerlink CB Brouwer JA Rauwerda CD Stehouwer YM Smulders 2006 No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk Clin Endocrinol 64 5 495 501 10.1111/j.1365-2265.2006.02497. x 1:CAS:528:DC%2BD28XlvFSrsr4%3D 10.1111/j.1365-2265.2006.02497.x
46. S Ziegler F Mittermayer C Plank E Minar M Wolzt GH Schernthaner 2005 Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease J Clin Endocrinol Metab 90 2175 2178 1:CAS:528:DC%2BD2MXjsFWjtbY%3D 10.1210/jc.2004-1087 (Pubitemid 40586258)
47. K Sydow E Schwedhelm N Arakawa SM Bode-Boger D Tsikas B Hornig, et al. 2003 ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins Cardiovasc Res 57 1 244 252 10.1016/S0008-6363(02)00617-X 1:CAS:528:DC%2BD38XpslSlsLc%3D 10.1016/S0008-6363(02)00617-X (Pubitemid 36009457)
48. KB Holven TS Haugstad T Holm P Aukrust L Ose MS Nenseter 2003 Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects Br J Nutr 89 3 359 363 10.1079/BJN2002779 1:CAS:528:DC%2BD3sXjt1Wnsrc%3D 10.1079/BJN2002779 (Pubitemid 36422777)
49. WM van Herpen-Broekmans IA Klopping-Ketelaars ML Bots C Kluft H Princen HF Hendriks, et al. 2004 Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation Eur J Epidemiol 19 10 915 921 10.1007/s10654-004-5760-z 10.1007/s10654-004-5760-z (Pubitemid 39434547)
50. ES Ford S Liu DM Mannino WH Giles SJ Smith 2003 C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults Eur J Clin Nutr 57 9 1157 1163 10.1038/sj.ejcn. 1601667 1:CAS:528:DC%2BD3sXmslemtbY%3D 10.1038/sj.ejcn.1601667 (Pubitemid 37121014)
51. N Bertran J Camps J Fernandez-Ballart V Arija N Ferre M Tous, et al. 2005 Diet and lifestyle are associated with serum C-reactive protein concentrations in a population-based study J Lab Clin Med 145 1 41 46 10.1016/j.lab.2004.11.002 1:CAS:528:DC%2BD2MXms1Gmsg%3D%3D 10.1016/j.lab.2004.11.002 (Pubitemid 40139076)
52. GN Fredrikson B Hedblad JA Nilsson R Alm G Berglund J Nilsson 2004 Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels Metabolism 53 11 1436 1442 10.1016/j.metabol. 2004.06.010 1:CAS:528:DC%2BD2cXovVKrs78%3D 10.1016/j.metabol.2004.06.010 (Pubitemid 39410383)
53. TY Chang KJ Chou CF Tseng HM Chung HC Fang YM Hung, et al. 2007 Effects of folic acid and vitamin B complex on serum C-reactive protein and albumin levels in stable hemodialysis patients Curr Med Res Opin 23 8 1879 1886 10.1185/030079907X218077 1:CAS:528:DC%2BD2sXhtFejtrjP 10.1185/030079907X218077 (Pubitemid 47300387)
54. O Bleie AG Semb H Grundt JE Nordrehaug SE Vollset PM Ueland, et al. 2007 Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease J Intern Med 262 2 244 253 10.1111/j.1365-2796.2007.01810.x 1:CAS:528:DC%2BD2sXhtVens7bM 10.1111/j.1365-2796.2007.01810.x (Pubitemid 47087627)
55. M Klerk J Durga EG Schouten C Kluft FJ Kok P Verhoef 2005 No effect of folic acid supplementation in the course of 1 year on haemostasis markers and C-reactive protein in older adults Thromb Haemost 94 1 96 100 10.1160/TH04-08-0524 1:CAS:528:DC%2BD2MXms12ks7o%3D (Pubitemid 40974712)
56. Bakhru A, Erlinger TP (2005) Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2(6):e160. doi: 10.1371/journal.pmed.0020160 (Pubitemid 40973506)
57. CA Northrop-Clewes DI Thurnham 2007 Monitoring micronutrients in cigarette smokers Clin Chim Acta 377 1-2 14 38 10.1016/j.cca.2006.08.028 1:CAS:528:DC%2BD28XhtleisLvK 10.1016/j.cca.2006.08.028 (Pubitemid 44914064)
58. SG Wannamethee GD Lowe AG Shaper A Rumley L Lennon PH Whincup 2005 Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease Eur Heart J 26 17 1765 1773 10.1093/eurheartj/ehi183 1:CAS:528: DC%2BD2MXhtFSkt7fP 10.1093/eurheartj/ehi183 (Pubitemid 41219850)
59. J Danesh JG Wheeler GM Hirschfield S Eda G Eiriksdottir A Rumley, et al. 2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 14 1387 1397 1:CAS:528:DC%2BD2cXivVagsbc%3D 10.1056/NEJMoa032804 (Pubitemid 38419992)
60. Emerging Risk Factors Collaboration, Danesh J, Erqou S, Walker M, Thompson SG, Tipping R, et al. (2007) The emerging risk factors collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 22(12):839-869. doi: 10.1007/s10654-007-9165-7
61. Helmersson J, Larsson A, Vessby B, Basu S (2005) Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 181(1):201-207. doi: 10.1016/j.atherosclerosis.2004.11.026 (Pubitemid 40812327)
62. Z Zhang YY Zou Y Zhou H Zhou YJ Li 2009 The aggravatory effect of nicotine on Helicobacter pylori-induced gastric mucosa injury: role of asymmetric dimethylarginine J Clin Gastroenterol 43 3 261 266 10.1097/MCG.0b013e3181624485 1:CAS:528:DC%2BD1MXit1Cgsb0%3D 10.1097/MCG. 0b013e3181624485
63. R Schnabel S Blankenberg E Lubos KJ Lackner HJ Rupprecht C Espinola-Klein, et al. 2005 Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene study Circ Res 97 5 e53 e59 10.1161/01.RES. 0000181286.44222.61 1:CAS:528:DC%2BD2MXpsVWrurc%3D 10.1161/01.RES.0000181286. 44222.61
64. WZ Zhang K Venardos J Chin-Dusting DM Kaye 2006 Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress Hypertension 48 2 278 285 10.1161/01.HYP.0000231509.27406.42 1:CAS:528:DC%2BD28XmvFalu7w%3D 10.1161/01.HYP.0000231509.27406.42 (Pubitemid 44309824)
65. Sobczak A, Goniewicz ML, Szoltysek-Boldys I (2009) ADMA and SDMA levels in healthy men exposed to tobacco smoke. Atherosclerosis 205(2):357-359. doi: 10.1016/j.atherosclerosis.2008.12.039
66. A Onat G Hergenc G Can A Karabulut 2008 Serum asymmetric dimethylarginine levels among Turks: association with metabolic syndrome in women and tendency to decrease in smokers Turk Kardiyol Dern Ars 36 1 7 13